July 16, 2018

AcuityBio Corporation to Present at the 144th NIBA Investment Conference

NEW YORK CITY, NY / ACCESSWIRE /July 16, 2018 / AcuityBio Corporation ( is a private company, focused on preventing post-surgical lung cancer recurrence via targeted drug-delivery. AcuityBio’s first product candidate is “ABC103,” their innovative drug-device combinat...

Please reload

Copyright © AcuityBio Corporation 2018. All rights reserved.

Primary Contact: 

Created by Brodly Inc.